论文部分内容阅读
目的为提高小儿急性肺炎治疗效果,针对维生素K_1及654-2辅佐治疗的康复疗效进行研究。方法选取2014年1月-2015年1月,到该院进行治疗的58例小儿支气管肺炎患儿。将患儿随机分为两组,观察组29例,对照组29例;所有患儿均采用常规小儿急性肺炎治疗;观察组患儿在常规治疗3d后,增加维生素K1及654-2辅佐治疗;对比两组患儿的康复疗效。结果观察组患儿经过维生素K_1及654-2辅佐治疗有效率(96.55%)明显高于对照组(75.86%),差异有统计学意义(P<0.05)。结论维生素K,及654-2辅佐治疗能够提高小儿急性肺炎患儿的治疗效果,缩短病程,有利于促进患儿康复,具有较高的应用价值。
Objective To improve the therapeutic effect of children with acute pneumonia, vitamin K_1 and 654-2 adjuvant therapy rehabilitation efficacy study. Methods From January 2014 to January 2015, 58 children with bronchopneumonia were treated in this hospital. The children were randomly divided into two groups, the observation group of 29 cases, the control group of 29 cases; all children were treated with conventional pediatric acute pneumonia; observation group of children in the conventional treatment of 3d, increased vitamin K1 and 654-2 adjuvant therapy; The rehabilitation efficacy of two groups was compared. Results The effective rate (96.55%) in the observation group after vitamin K 1 and 654-2 adjuvant therapy was significantly higher than that in the control group (75.86%), the difference was statistically significant (P <0.05). Conclusion Vitamin K and adjuvant therapy with 654-2 can improve the therapeutic effect of children with acute pneumonia in children, shorten the course of the disease and promote the recovery of children with high value.